<html>
<head><title>
Prepared and filed by St Ives Financial
</title>
</head>
<body bgcolor="#FFFFFF">
<page>
<p align="center"><font size="2" face="serif"><b>UNITED STATES<br>
SECURITIES AND EXCHANGE COMMISSION<br>
Washington, D.C. 20549</b></font></p>
<p align="center"><b><font face="serif" size="4">FORM 8-K</font></b></p>
<p align="center"><font size="2" face="serif"><b>CURRENT REPORT<br>
</b></font><font size="2" face="serif"><b>Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934</b></font></p>
<p align="center"><font size="2" face="serif">Date of report (Date of earliest event reported):  January 8, 2007</font></p>
<table width="100%" cellspacing="0" cellpadding="0" border="0">
<tr valign="top">
<td width="3%"><font size="2" face="serif">&nbsp;</font></td>
<td align="center"><font size="2" face="serif"><b><u>Impax Laboratories, Inc.</u></b></font></td>
</tr>
</table>
<table width="100%" cellspacing="0" cellpadding="0" border="0">
<tr valign="top">
<td width="3%"><font size="2" face="serif">&nbsp;</font></td>
<td align="center"><font size="2" face="serif">(Exact name of registrant as specified in its charter)</font></td>
</tr>
</table>
<table width="100%" cellspacing="0" cellpadding="0" align="center" border="0">
<tr valign="top">
  <td align="left">&nbsp;</td>
  <td align="left">&nbsp;</td>
  <td align="right">&nbsp;</td>
  <td align="left">&nbsp;</td>
  <td align="right">&nbsp;</td>
  </tr>
<tr valign="top">
<td align="center"><font size="2" face="serif"><b><u>Delaware</u></b></font></td>
<td align="left" width="2%">&nbsp;</td>
<td width="30%" align="center"><font size="2" face="serif"><b><u>0-27354</u></b></font></td>
<td width="2%" align="left">&nbsp;</td>
<td width="34%" align="center"><font size="2" face="serif"><b><u>65-0403311</u></b></font></td>
</tr>
<tr valign="top" bgcolor="#FFFFFF">
<td align="center"><font size="2" face="serif">(State or other jurisdiction</font><br><font size="2" face="serif">of incorporation)</font></td>
<td align="left">&nbsp;</td>
<td align="center"><font size="2" face="serif">(Commission</font><br><font size="2" face="serif">File Number)</font></td>
<td align="left">&nbsp;</td>
<td align="center"><font size="2" face="serif">(I.R.S. Employer</font><br><font size="2" face="serif">Identification No.)</font></td>
</tr>
</table>
<br>
<table width="100%" cellspacing="0" cellpadding="0" border="0">
<tr valign="top">
<td align="center"><font size="2" face="serif"><b><u>30831 Huntwood Ave., Hayward, CA 94544</u></b></font></td>
</tr>
<tr valign="top">
<td align="center"><font size="2" face="serif">(Address of principal executive offices) (Zip Code)</font></td>
</tr>
</table>
<br>
<table width="100%" cellspacing="0" cellpadding="0" align="left" border="0">
<tr valign="top">
<td align="center"><font size="2" face="serif"><b><u>510-476-2000</u></b></font></td>
</tr>
<tr valign="top" bgcolor="#FFFFFF">
<td align="center"><font size="2" face="serif">(Registrant&#8217;s telephone number, including area code)  </font></td>
</tr>
</table>
<br><br>
<table width="100%" cellspacing="0" cellpadding="0" border="0">
<tr valign="top">
<td align="center"><font size="2" face="serif"><b><u>Not Applicable</u></b></font></td>
</tr>
<tr valign="top">
<td align="center"><font size="2" face="serif">(Former name or former address, if changed since last report)</font></td>
</tr>
</table>
<p align="left"><font size="2" face="serif">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):</font></p>
<p align="left"><font size="2" face="serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<img src="emptybox.gif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</font></p>
<p align="left"><font size="2" face="serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<img src="emptybox.gif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</font></p>
<p align="left"><font size="2" face="serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<img src="emptybox.gif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</font></p>
<p align="left"><font size="2" face="serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<img src="emptybox.gif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</font></p>
<p align="center">&nbsp;</p>
<hr noshade align="center" width="100%" size="2">
<div style="page-break-before:always"></div>
<page>
<a name="p?"></a>
<p align="left"><font size="2" face="serif"><b>Item 8.01&nbsp;&nbsp;&nbsp;Other Events.</b></font></p>
<p align="left"><font size="2" face="serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;On January 8, 2007, the registrant files with the Securities and Exchange Commission its Answer to the Commission&#8217;s Order dated December 29, 2006 instituting an administrative proceeding to determine whether the registration of the registrant&#8217;s securities under Section 12 of the Securities Exchange Act of 1934 should be suspended or revoked.   A copy of the Answer is attached as Exhibit 99.1 to this Report.</font></p>
<p align="left"><font size="2" face="serif"><b>Item 9.01&nbsp;&nbsp;&nbsp;Financial Statements and Exhibits.</b></font></p>
<p align="left"><font size="2" face="serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;                  (d)  Exhibits.</font></p>
<p align="left"><font size="2" face="serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 99.1 &#150; Answer of Respondent Impax Laboratories, Inc. filed January 8, 2007.</font></p>
<p align="center"><font size="2" face="serif"></font></p>
<hr noshade align="center" width="100%" size="2">
<div style="page-break-before:always"></div>
<page> <a name="p?"></a>
<p align="center"><font size="2" face="serif"><b>EXHIBIT INDEX</b></font></p>
<table width="100%" cellspacing="0" cellpadding="0" align="center" border="0">
<tr valign="top">
<td align="left"><font size="2" face="serif"><u>Exhibit No.</u></font></td>
<td align="left">&nbsp;</td>
<td align="left"><font size="2" face="serif"><u>Description</u></font></td>
</tr>
<tr valign="top">
<td align="left"><font size="2" face="serif">&nbsp;</font></td>
<td align="left">&nbsp;</td>
<td align="left"><font size="2" face="serif">&nbsp;</font></td>
</tr>
<tr valign="top">
<td width="10%" align="center"><font size="2" face="serif">99.1</font></td>
<td width="2%" align="left">&nbsp;</td>
<td align="left"><font size="2" face="serif">Answer of Respondent Impax Laboratories, Inc. filed January 8, 2007</font></td>
</tr>
</table>
<p align="center"><font size="2" face="serif"></font></p>
<hr noshade align="center" width="100%" size="2">
<div style="page-break-before:always"></div>
<page> <a name="p?"></a>
<p align="center"><font size="2" face="serif"><b>SIGNATURES</b></font></p>
<p align="left"><font size="2" face="serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</font></p>
<p align="left"><font size="2" face="serif">Dated:  January 9, 2007</font></p>
<table width="100%" cellspacing="0" cellpadding="0" border="0">
<tr valign="top">
<td width="50%"><font size="2" face="serif">&nbsp;</font></td>
<td colspan="2"><font size="2" face="serif">&nbsp;</font><font size="2" face="serif">IMPAX
    LABORATORIES, INC.</font></td>
</tr>
<tr valign="top">
  <td>&nbsp;</td>
  <td>&nbsp;</td>
  <td align="left">&nbsp;</td>
</tr>
<tr valign="top">
<td><font size="2" face="serif">&nbsp;</font></td>
<td width="5%"><font size="2" face="serif">By:</font></td>
<td align="left"><font size="2" face="serif"><u>/s/ Arthur A. Koch, Jr.</u></font></td>
</tr>
<tr valign="top">
<td><font size="2" face="serif">&nbsp;</font></td>
<td><font size="2" face="serif">Name:</font></td>
<td align="left"><font size="2" face="serif">Arthur A. Koch, Jr.</font></td>
</tr>
<tr valign="top">
<td><font size="2" face="serif">&nbsp;</font></td>
<td><font size="2" face="serif">Title:</font></td>
<td align="left"><font size="2" face="serif">Chief Financial Officer</font></td>
</tr>
</table>
<p align="center">&nbsp;</p>
<hr noshade align="center" width="100%" size="2">
</body>
</html>
[{"type": "8-K", "sequence": "1", "filename": "b416735_8k.htm", "description": "FORM 8-K", "secsgml_size_bytes": 8504}]
{"company-data": {"conformed-name": "IMPAX LABORATORIES INC", "cik": "0001003642", "assigned-sic": "2834", "irs-number": "650403311", "state-of-incorporation": "DE", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "000-27354", "film-number": "07520666"}, "business-address": {"street1": "30831 HAYWARD AVE", "city": "HAYWARD", "state": "CA", "zip": "94544", "phone": "2152892220"}, "mail-address": {"street1": "CASTOR & KENSINGTON AVENUES", "city": "PHILADELPHIA", "state": "PA", "zip": "19124-5694"}, "former-company": {"former-conformed-name": "GLOBAL PHARMACEUTICAL CORP \\DE\\", "date-changed": "19951117"}}
Prepared and filed by St Ives Financial
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of report (Date of earliest event reported):  January 8, 2007
Impax Laboratories, Inc.
(Exact name of registrant as specified in its charter)
Delaware
0-27354
65-0403311
(State or other jurisdiction
of incorporation)
(Commission
File Number)
(I.R.S. Employer
Identification No.)
30831 Huntwood Ave., Hayward, CA 94544
(Address of principal executive offices) (Zip Code)
510-476-2000
(Registrant's telephone number, including area code)
Not Applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 8.01   Other Events.
On January 8, 2007, the registrant files with the Securities and Exchange Commission its Answer to the Commission's Order dated December 29, 2006 instituting an administrative proceeding to determine whether the registration of the registrant's securities under Section 12 of the Securities Exchange Act of 1934 should be suspended or revoked.   A copy of the Answer is attached as Exhibit 99.1 to this Report.
Item 9.01   Financial Statements and Exhibits.
(d)  Exhibits.
99.1 – Answer of Respondent Impax Laboratories, Inc. filed January 8, 2007.
EXHIBIT INDEX
Exhibit No.
Description
99.1
Answer of Respondent Impax Laboratories, Inc. filed January 8, 2007
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Dated:  January 9, 2007
IMPAX
    LABORATORIES, INC.
By:
/s/ Arthur A. Koch, Jr.
Name:
Arthur A. Koch, Jr.
Title:
Chief Financial Officer